LINSEY HANEY: Open Payments
NPI 1083258503 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$530 in 29 payments from 16 companies in 2025. Trend: 2023 $124 · 2024 $0 · 2025 $530
Food & beverage: $530
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 4 | $70 |
| AstraZeneca Pharmaceuticals LP | 4 | $67 |
| Daiichi Sankyo Inc. | 3 | $59 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $51 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $44 |
| Noven Therapeutics, LLC | 2 | $36 |
| PFIZER INC. | 2 | $36 |
| Exact Sciences Corporation | 1 | $27 |
| ABIOMED | 1 | $26 |
| Novo Nordisk Inc | 1 | $19 |
Products named: MOUNJARO, INJECTAFER, AIRSUPRA, Kerendia, XIFAXAN, Xelstrym, NURTEC ODT, Cologuard Collection Kit.
Industry payments across FL — which companies pay providers there.
